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The purpose of this study was to describe the clinical features at onset and outcome and the diagnostic approach in
subjects with bronchiolitis obliterans-organizing pneumonia (BOOP). Over a 7-year period we observed 78 cases of
biopsy-proven bronchiolitis obliterans-organizing pneumonia, in which well documented clinical and radiographic
data were available. The final diagnosis of BOOP was validated when patients presented: (i) negative
microbiological analysis on BAL fluid; (ii) a well documented improvement either spontaneous, or after steroid
treatment or (iii) cases with progressive respiratory failure and increasing radiographic shadows, an open lung
biopsy or autopsy that excluded other entities. There were 42 males and 36 females; the mean age was 6112 years
(range 12–85 years). Forty-two (54%) patients were current smokers, 25 (32%) had never smoked and 11 (14%)
were ex-smokers. The clinical pattern at presentation of BOOP was more frequently similar to classical acute or
sub-acute infectious pneumonia. Fever (63%), dyspnoea (58%) and dry cough (53%) were the typical symptoms on
admission. A flu-like syndrome preceeding BOOP was observed in 21 cases (27%). Inspiratory crackles (78%) were
the most typical finding at physical examination. However, 13% of the patients were asymptomatic and an
abnormal chest X-ray film was the reason for seeking medical attention. Radiographically the most frequent pattern of
BOOP was a unilateral consolidation (44%) with lower field predominance. A migratory behaviour was present in 22%
of the cases. High-resolution computed tomographic (HR-CT) scan when performed, was more sensitive in detecting
ground glass infiltrates, sub-pleural or peri-bronchovascular distribution or the presence of nodules or cavitation.
Most patients (68%) were classified as having idiopathic BOOP. However, the same clinical-roentgenological
pattern was observed in patients after radiotherapy for ductal breast carcinoma (6%), in collagen-vascular diseases
(6%), related to drugs (9%), to infections serologically documented (4%), and to graft vs. host disease (4%).
Four patients (all of whom had idiopathic BOOP) presented a rapid progressive respiratory failure needing
mechanical ventilation. In another two cases respiratory failure appeared after a long period during which patients
experienced exertional dyspnoea and low grade fever.
BAL profile was characterized by lymphocytosis with a reduction of the CD4/CD8 ratio, associated with a slight
increase of neutrophils and eosinophils and scattered mast cells. However in two cases we had an increased CD4/
CD8 ratio and in one case the presence of a significant 12% of polyclonal B cells. In a few cases atypical
(cytokeratin-positive cells) epithelial cells were detected: these cells were constantly present in the BAL fluid of
patients with rapidly progressive respiratory failure.
From the diagnostic point of view this series documents that transbronchial lung biopsy (coupled with BAL) can
be the first diagnostic step. However, therapy can be started on the basis of BAL data (when a characteristic
morphological and phenotypical profile is evident) in cases in which the clinical presentation is suggestive and a
biopsy cannot be made. Most patients showed a rapid and good response to steroid therapy. However, three
patients died (4%) in spite of steroid therapy (two cases) and steroid and cyclophosphamide therapy (one case).
In conclusion, although clinical findings, chest X-ray film and CT Scan findings usually suggest the diagnosis a
definite confirmation requires transbronchial lung biopsy and BAL and, less frequently, open lung biopsy.
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Bronchiolitis obliterans-organizing pneumonia (BOOP) is a
distinct clinicopathological entity which usually responds
significantly to corticosteroids (1–6). Most cases of BOOP
are idiopathic (in this case a synonym used in Europe is
cryptogenic organizing pneumonia). It may also occur in
association with connective tissue disease, with variable
immunodeficiency syndrome, HIV infection, hepatitis viral
infection, bacterial infections, graft vs. host disease
(GVHD) and bone marrow transplant (BMT), with lung
transplant, drug toxicity, radiation toxicity or it may be
associated with lung tumours, ulcerative colitis and
myelodysplastic syndrome. Spiteri and Coll reported a
seasonal occurence of BOOP with biochemical cholestasis
(7). Exposure to paint aerosols in textile workshops has
been reported as a novel cause of bronchilitis obliterans-
organizing pneumonia (8).
Pathogenetic studies have provided evidence of an
increase in lung microenviroment in the number of
activated T-lymphocytes, indicative of an immune re-
sponse, and hence the production of cytokines and growth
factors (9). Mast cell hyperplasia and evidence for extra-
cellular release of tryptase have been documented on
bronchoalveolar lavage (BAL) fluid (10). Increased inter-
leukin 8 (IL-8) and interleukin 6 (IL-6) mRNA expression,
platelet-derived growth factor (PDGF) and granulocyte/
macrophage colony-stimulating factor (GM-CSF) immu-
noreactivity have also been found in lung specimens
obtained from patients with BOOP (9,11–13). Most
patients experience a good response to therapy but a few
series have reported cases with rapidly progressive BOOP
(14). Bronchoalveolar lavage findings are characteristic and
BAL coupled with transbronchial lung biopsy may be
sucient for a definitive diagnosis although surgical lung
biopsy has till now been considered necessary in order to
confirm a clinical diagnosis (15–17).
The purpose of this study was to describe the clinical and
roentgenological features at onset and outcome and the
diagnostic approach in subjects with bronchiolitis obliter-
ans-organizing pneumonia. Over a 7-year period we
observed 78 cases of biopsy-proven BOOP in which well
documented clinical and radiographic data were available.
Materials and methods
From January 1990 to December 1997 we observed 78 cases
of biopsy-proven BOOP. All patients were studied for
connective tissue disease, ANCA antibodies, serological
assays for Mycoplasma pneumoniae, Chlamydia trachoma-
tis, Legionella pneumophila, Coxiella burneti, Adenovirus,
respiratory syncitial virus, Cytomegalovirus, Herpes sim-
plex virus, Hepatitis virus (HBV, HCV), Influenza and
Parainfluenza virus. Chlamydia pneumoniae serological
assay has been performed only recently (for 2 years).
Clinical evaluation included immunological status, drug
consumption, symptoms at presentation, routine biochem-
ical data, medication requirement and outcome.The radiographs were reviewed by experienced radiolo-
gists. The patterns of abnormalities were classified as
airspace consolidation (unilateral or bilateral, migratory
or fixed), nodules or reticulonodular. HRCT scan films
from patients with non-pseudoneoplastic lesions were
available in 35 patients. All the lung specimens and BAL
slides were reviewed by experienced pulmonary patholo-
gists. A BOOP pattern was defined when histological
changes characterized by patchy airspace organization with
buds of loose connective tissue containing fibroblast and
inflammatory cells within airspaces (bronchioles and
alveolar spaces) were present on lung tissue specimens.
All patients enrolled in the study were required to meet
the following criteria: (i) radiologic lung infiltrate(s) or
nodule(s); (ii) lung biopsy confirming BOOP; (iii) negative
microbiological analysis on BAL fluid; (iv) a well docu-
mented improvement that was either spontaneous, or after
exclusive steroid treatment; (v) cases with progressive
respiratory failure and increasing radiographic shadows,
an open lung biopsy or autopsy that excluded other entities.
Results
PATIENTS’ CHARACTERISTICS
During the 7-year study, 78 patients were identified with a
confirmatory diagnosis of organizing pneumonia or BOOP.
There were 42 males and 36 females in the study, with an
age range of 12–85 years; the age meanSD was 6112
years. Forty-two patients (54%) were current smokers, 25
(32%) had never smoked and 11 (14%) were ex-smokers
(they had stopped smoking at least 12 months before the
diagnosis was made).
CLINICAL MANIFESTATIONS AND
ASSOCIATED CONDITIONS
Clinical features are summarized in Table 1. The most
common presenting symptoms were dyspnoea and fever
lasting from 1 week to 7 months (11085 days). Four
patients (all of whom had idiopathic BOOP) presented a
rapid progressive respiratory failure needing mechanical
ventilation. In two cases dyspnoea and fever were present
14 and 24 days respectively before admission. In the other
two cases the duration of symptoms (fever, asthenia and
eort dyspnoea) before admission to the respiratory
intensive care unit was 3 and 7 months respectively. Fever
was continuous and low-grade or intermittent in 32 patients
(41%); 18 patients (23%) were admitted to the hospital for
acute fever consistent with a diagnosis of acute bacterial
pneumonia. A flu-like syndrome for the 3–4 weeks
preceeding BOOP was described in 21 patients (27%).
Physical examination revealed inspiratory crackles in 61
cases (78%) and wheezing in 20 cases (26%).
The clinical variants of BOOP are reported in Table 2.
Most of the patients [52 cases (68%)] had no associated
condition and were reported as idiopathic; in five cases
(6%) BOOP was related to radiotherapy for ductal breast
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tion of radiotherapy (46–50 Grays delivered) and the
radiographic shadows (in every case the first radiographic
lesion was observed under the irradiated area) were
migratory in four cases.
Four patients had connective tissue disease (two rheu-
matoid arthritis, one polymiositis, and one systemic lupus
erythematosus). Another later developed polymiositis. In
seven cases BOOP was related to drug toxicity (amiodarone
in four cases, polychemotherapy for acute myelogenous
leukaemia and carcinoma of the stomach in two cases,TABLE 1. Clinical features of patients with BOOP
Sex and age
Male/Female 42/36
Mean age 6112 yrs (range 12–85 yrs)
Smoking habit
Current smokers 42 (54%)
Non-smokers 25 (32%)
Ex-smokers 11 (14%)
Symptoms and Signs
Fever 49 (63%)
Dyspnoea 45 (58%)
Cough 41 (53%)
Asthenia 30 (38%)
Weight loss 10 (13%)
Arthralgia 5 (6%)
Thoracic pain 2 (3%)
Abdominal pain 1 (1%)
Headache 1 (1%)
Haemopthysis 1 (1%)
Crackles 61 (78%)
Wheezing 20 (26%)
Clubbing 0
Asymptomatic 10 (13%)
TABLE 2. Clinical variants of BOOP in the population study
Idiopathic 53 (68%)
Diuse infiltrates 43
Focal or nodular variant 10
Secondary
Drugs 7 (9%)
Radiotherapy 5 (6%)
Connective tissue disease 5 (6%)
Bacterial infections 3 (4%)
Mycoplasma pn. 2
Chlamydiae pn. 1
Chronic viral hepatitis 2 (3%)
Autologous bone marrow 2 (3%)
Allogenic bone marrow 1 (1%)pyrimethamine-sulfadiazine in a 12-year-old girl with
primary toxoplasma infection). Serological assays demon-
strated a recent Mycoplasma pneumoniae infection in two
cases and Chlamydia pneumoniae infection in one case. In
all three cases we observed a clear clinical and roentgen-
ological improvement only after steroid therapy. Two
patients developed organizing pneumonia 60 and 360 days
respectively after their allogenic bone marrow transplant
for acute myelogenous leukaemia. Both patients had
manifestations of graft vs. host disease. In one patient
BOOP developed 120 days after autologous bone marrow
transplantation for non-Hodgkin lymphoma (BCNU, EDX
and VP were used for induction).
ROENTGENOGRAPHIC MANIFESTATIONS
The radiographic abnormalities are recorded in Table 3.
Patchy, unilateral consolidation was seen in 34 cases (44%),
with a migratory behaviour in nine patients (12%).
Bilateral patchy acinar shadows were observed in 31
patients (40%), and were preceeded in eight patients
(10%) by a unilateral acinar lesion. In 10 cases (13%) the
chest X-ray film showed a nodular (pseudoneoplastic)
lesion and in three cases a bilateral reticulonodular pattern
was described.
The shadows were observed in the upper lung fields in 23
cases (29%) and predominantly in the lower fields in 55
patients (71%). Unilateral small pleural eusions were
present in four cases (5%).
HRCT scan findings are reported in Table 4. Pleural
based alveolar opacification was the more frequent aspect.
However areas of ground glass attenuation were detected in
2/13, in which radiographically the lesion appeared to be
focal. Halo sign, atoll sign and centrilobular nodules were
rarely detected.
BRONCHOALVEOLAR LAVAGE
Bronchoalveolar lavage analysis was completed in 67 cases
(86%). Total number of cells was 418229 (6103ml71).
Lymphocytes were 450225% of total cells. In detail, a
lymphocytosis of more than 25% was observed in 41 cases
(61%) and in these cases the mean value of lymphoid cells
was 567165%. The CD4/CD8 ratio was less than one in
30 cases (45%) and greater than 27 in only two cases (5 andTABLE 3. Radiographic findings in 78 patients with BOOP
Pattern of opacities
Patchy consolidation
Unilateral 34 (44%)
Bilateral 31 (40%)
Nodular 10 (13%)
Reticulonodular 3 (4%)
Associated findings
Pleural eusion 4 (5%)
Cavities 1 (1%)
TABLE 4. HRCT scan findings in 35 cases of non-pseudoneoplastic BOOP
Radiographic pattern n cases HRCT findings n cases
Patchy unilateral consolidation 13 Pleural based alveolar opacification 8
Peri-bronchovascular alveolar opacification 3
Pleural based alveolar opacification associated with
areas of ground glass attenuation (not detected in chest
X-ray films)
2
Patchy bilateral consolidation 20 Extensive bilateral areas of alveolar opacification 20
Associated areas of ground glass attenuation also
present
13
Halo sign* 2
Atoll sign{ 1
Cavitated area 1
Reticulonodular 2 Areas of alveolar and ground glass consolidation with a
mixed peribronchial and sub-pleural distribution
1
Centrilobular nodules 1
*Halo sign=an alveolar opacification rounded area surrounded by peripheral ground glass attenuation.
{Atoll sign=peripheral, rounded area of consolidation, surrounding a central ground glass opacity, resembling an atoll.
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34 cases (51%).
Neutrophils were slightly increased (86117%). In
detail neutrophils in BAL fluid were more than 5% in 21
patients (31%): in these cases the mean value of neutrophils
was 173144%. In patients with rapid respiratory failure
neutrophils were 44%, 39%, 30% and 14% respectively.
Eosinophils were slightly increased (>1% of total non-
epithelial cells) in 30 (45%) cases (meanSD 51529%).
Mast cells were detected in 16 (24%) cases (meanSD
23214%) and plasma cells were significantly increased
(6%) in only one case. No phenotypical B cells (CD20-
positive cells) were higher in percentage except in one case
(in which they were 12%, with politypic expression of light
chains). In six cases atypical epithelial cells (marked by
monoclonal antibodies against low weight cytokeratins)
were observed. In four cases these cells were detected in
patients with evident respiratory failure and in another two
cases with an alveolar infiltrate suggesting infection or
alveolar cell carcinoma. In all cases a diagnosis of alveolar
cell carcinoma was excluded by surgical (five cases) or
autopic (one case) examinations. In two cases these cells
were associated with extracellular amorphous cyanophilic
material.
DIAGNOSTIC PROCEDURES
Fifty-eight patients (74%) had a diagnosis of BOOP on
transbronchial lung biopsy (TBB) specimens. In 18 cases
(23%) the diagnosis was made on surgical biopsy specimens
(thoracotomy or video-assisted thoracoscopic biopsy). In
one case transthoracic biopsy was diagnostic. In one case
the diagnosis was confirmed on autoptic specimens. In
particular, in the group of patients with respiratory failure
needing mechanical ventilation, the diagnosis was con-
firmed by transbronchial lung biopsy (n=2) (in both casessteroid treatment determined a rapid clinico-radiological
improvement), by open lung biopsy (n=1) (the patient died
2 weeks after surgical biopsy in spite of treatment) and after
autopsy (n=1). Lung biopsy specimens were considered
positive for BOOP if they showed buds of granulation
tissue (Masson bodies) within the small airways and alveoli,
the infiltration of alveolar walls with chronic inflammatory
cells and the preservation of alveolar architecture.
In the present study BAL results were consistent with the
clinical diagnosis of BOOP in nine cases in which TBB was
not diagnostic in agreement with arbitrary cut-o levels for
the BAL percentage previously described (lymphocytosis
more than 25% with a CD4/CD8 ratio5 09, combined
with at least two of the following criteria: foamy macro-
phages>20% and/or neutrophils of>5% and/or eosino-
phils>2% and5 25%) (17).
LABORATORY DATA
Erythrocyte sedimentation rate (ERS) was over 30mm h71
in the first hour in 63 cases (81%). Lactate-dehydrogenase
(LDH) was above normal in 18 cases (23%). A slight
eosinophilia was observed in six cases (8%). In one case
biochemical cholestasis was detected. Anti-neutrophil
cytoplasmic antibodies (ANCA) were negative in all cases
whereas anti-nuclear antibodies (ANA) were positive in two
patients (without a connective-vascular disease).
TREATMENT AND OUTCOME
Sixty patients (77%) received methyl-prednisolone therapy.
The mean dose was 40mg (range 20–120mg day71) for 6
weeks, then tapering to a lower dosage for 6–9 months. In
this group of patients we had a recurrence of symptoms and
chest X-ray abnormalities on reducing the dose of methyl-
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(26%).
Three patients died (4%) in spite of steroid (two cases)
and steroid plus cyclophosphamide therapy (one case). All
cases were classified as idiopathic BOOP. In two patients a
BOOP pattern was detected in both lungs at autopsy; in the
last one at autopsy BOOP and DAD (exudative phase)
findings were present. In one case respiratory failure
appeared after a long period in which fever and dyspnoea
on eort were the symptoms reported. In the second case
rapid respiratory failure appeared during the BOOP relapse
after 1 month of steroid withdrawal. In the third case
respiratory failure was present from the start and the
patient died after 40 days of therapy.
Five patients (asymptomatic patients with cryptogenic
organizing pneumonia and roengenological patchy alveolar
pattern) recovered spontaneously. In 10 patients with
pseudoneoplastic nodules surgery was curative.
Discussion
Most patients in this large series were classified as having
idiopathic BOOP. The clinical pattern at presentation of
BOOP was more frequently similar to classical acute or
sub-acute infectious pneumonia. Fever, dyspnoea, and dry
cough were the typical symptoms at admission. A flu-like
syndrome preceeding BOOP was observed in 21 cases
(27%). Inspiratory crackles were the most typical finding at
physical examination. However 13% of the patients were
asymptomatic and a nodular shadow on chest X-ray film
was the reason for seeking medical attention. It is well
documented that the characteristic roentgenographic fea-
ture of BOOP is patchy air-space consolidation. This
pattern was seen in 88% of the cases of this series. In
44% of the cases there was a unilateral consolidation with
lower field predominance. This data, not completely in
agreement with other series (4,5), could be explained by the
fact that we used bronchoscopic procedures routinely in
patients with alveolar shadows on chest X-ray film. It is
interesting to note that a migratory behaviour was present
in 22% of the cases. This was thought to be a characteristic
feature of eosinophilic pneumonia but it is well also
documented for BOOP (5). HRCT scan, when performed
was more sensitive to detect ground glass infiltrates and a
more diuse parenchymal involvement, the sub-pleural or
peri-bronchovascular distribution of the lesions or the
presence of nodules (18). The HRCT scan findings at
presentation are, however, non-specific and the dierential
diagnosis should include various entities (18).
In two cases (25%) a rapid progressive respiratory
failure needing mechanical ventilation was observed. In
another two cases respiratory failure appeared after a long
period, during which patients experienced exertional
dyspnoea and low-grade fever. In one of these last two
cases at autopsy patchy areas of bronchiolitis obliterans-
organizing pneumonia (BOOP) and diuse alveolar damage
(DAD) in exudative phase were both documented. This
may be due to oxygen therapy but also suggests that a
phenomenon already described in usual interstitial pneu-monitis (UIP/accelerated phase) may be a cause of
respiratory deterioration, although rare, in BOOP. In fact,
Yousem et al. (19) reported that scarring and remodelling
of the background lung parenchyma may be a potential
morphologic marker of unfavourable outcome in BOOP
patients but other authors reported diuse alveolar damage
(exudative phase) in association with BOOP in patients
with rapidly progressive respiratory failure (14,20). BOOP
was related to infections (as documented by serology) in
three cases, and was successfully treated only with steroids
in all cases. These data suggest the possibility that in some
instances the aetiology may be an atypical response to an
infectious agent.
Secondary BOOP was observed in 25 cases (32%),
clinical profile and radiological patterns were similar to
those observed in diuse BOOP (idiopathic alveolar/
interstitial patchy variant).
Lymphocytosis with a reduction of the CD4/CD8 ratio
associated with a slight increase of neutrophils and
eosinophils and scattered mast cells are the BAL hallmark
of BOOP of known or cryptogenic aetiology (2,15,17,21).
However in two cases we had an increased CD4/CD8 ratio
and in one case the presence of a significant 12% of
polyclonal B cells. It is interesting to note that in a few cases
atypical (cytokeratin-positive cells) epithelial cells were
detected: these cells were constantly present in the BAL
fluid of patients with rapid progressive respiratory failure
and this data confirms the presence of some relationship
between BOOP and diuse alveolar damage as atypical
epithelial cells and extracellular amorphous material are a
cytological hallmark of diuse alveolar damage in its early
phases (22).
From the diagnostic point of view our study documents
that transbronchial lung biopsy (coupled with BAL) should
be the first diagnostic step. We had a diagnosis of BOOP by
TBB in 58 cases (74%), a diagnostic yield expected in
alveolar filling diseases epecially when more then five
specimens are obtained (16,17). Although the sensitivity of
BAL was found to be lower than TBB, the combination of
the two procedures improved the diagnostic yield (sensitiv-
ity 86%). As described previously, we chose arbitrary cut-
o levels for the BAL percentages of cells (coupled with a
CD/CD8 ratio5 09) to consider the examination as
positive for BOOP. In addition, BAL is useful in order to
exclude other disorders in particular infectious diseases or
neoplastic alveolar filling processes (bronchioloalveolar cell
carcinoma and low grade B cell lymphoma of MALT type
that can be included in the dierential diagnosis list). Thus,
in our opinion, BAL can be useful and therapy can be
started on the basis of BAL data (when a characteristic
morphological and phenotypical profile is evident) in cases
in which the clinical presentation is suggestive and a biopsy
cannot be made (15,17).
In this study, although recurrence of symptoms and chest
X-ray abnormalities on reducing the steroid dose or shortly
after stopping therapy was observed in 26% of the cases,
most patients with diuse (idiopathic non-focal or nodular
variant) BOOP showed a rapid and good response to therapy.
However, three patients died in spite of steroid therapy
(two cases) and steroid and cyclophosphamide therapy (one
BRONCHIOLITIS OBLITERANS-ORGANIZING PNEUMONIA 707case). Respiratory failure was present from the start in only
one case. In the other two cases it appeared after a long
period in which more typical symptoms of BOOP were
present and a short course of steroid therapy was
performed without having a specific diagnosis. BAL
showed atypical cells in all cases with rapid progressive
respiratory failure. Neutrophils were higher in these
patients. Some authors suggested that a high lymphocytic
count may indicate a good response to therapy, whereas an
increase in neutrophils and/or eosinophils without an
additional increase in lymphocytes may predict a poor
response (14,21). In this series neutrophils increased in patients
with a poor prognosis but probably the presence of atypical
epithelial cells (best detected by Papanicolou stain), indicating
the presence of alveolar damage was more characteristic. This
element may have some prognostic significance.
In focal BOOP (idiopathic nodular variant) the surgery
was curative.
In conclusion, our study confirms that BOOP is probably
a more than trusted common idiopathic condition or is
related to a variety of causes. Although clinical findings,
chest X-ray film and CT scan findings usually suggest the
diagnosis, a definitive confirmation requires TBB and BAL
and less frequently open lung biopsy.
The prognosis is usually good but mortality related to the
disease is not negligible; BAL can give us elements to
predict response to therapy. How long the treatment should
be continued after initial recovery from BOOP to prevent
relapse is not yet known. Multi-centric studies with a large
number of patients are needed before definite conclusions
can be drawn on treatment, prognostic elements and risk
factors (23,24).
References
1. Epler GR, Colby TV, McLoud TC, et al. Bronchiolitis
obliterans organizing pneumonia. N Engl J Med 1985;
312: 152–158.
2. King TE, Mortenson RL. Cryptogenic organizing
pneumonia. The North American experience. Chest
1992; 102: 715–719.
3. Grimblat J, Mechlis S, Lewitus Z. Organizing pneu-
monia like process: an unusual observation in steroid
responsive cases with features of chronic interstitial
pneumonia. Chest 1981; 80: 259–263.
4. Izumi T, Kitaichi M, Nishimura K, Nagai S. Bronch-
iolitis obliterans organizing pneumonia. Clinical fea-
tures and dierential diagnosis. Chest 1992; 102: 715–
719.
5. Cordier JF. Cryptogenic organizing pneumonitis. Clin
Chest Med 1993; 14: 667–692.
6. Epler GR. Heterogeneity of bronchiolitis obliterans
organizing pneumonia. Curr Opin Pulm Med 1998; 4:
93–97.
7. Spiteri MA, Klenerman P, Sheppard MN, et al.
Seasonal cryptogenic organising pneumonia with bio-
chemical cholestasis: a new clinical entity. Lancet 1992;
340: 281–284.8. Camus P, Nemery B. A novel cause of bronchiolitis
obliterans organizing pneumonia: exposure to paint
aerosols in textile workhops. Eur Respir J 1998; 11:
259–262.
9. Poletti V, Castrilli G, Romagna M, et al. Bronchoal-
veolar lavage, histological and immunohistochemical
features in cryptogenic organizing pneumonia.Monaldi
Arch Chest Dis 1996; 51: 289–295.
10. Pesci A, Majori M, Piccoli ML, et al. Mast cells in
bronchiolitis obliterans organizing pneumonia. Mast
cells hyperplasia and evidence for extracellular release
of tryptase. Chest 1996; 110: 383–391.
11. Carre` C, King E, Mortensen R, Riches DWH.
Cryptogenic organizing pneumonia: increased expres-
sion of interleukin 8 and fibronectin genes by alveolar
macrophages. Am J Respir Cell Mol Biol 1994; 10:
100–105.
12. Carre` C, King E, Mortensen R, Riches DWH.
Surexpression des genes de l’ interleukine-6, de la
fibronectine et de l’ inhibiteur de l’activateur du
plasminogene par les macrophages alveolaires au cours
des bronchiolites obliterans idiopathique. Rev Mal
Respir 1990; 7: R200.
13. Aubert JD, Havashi S, Pare` PD, Hogg JC. Increased
expression of platelet-derived growth factor (PDGF)
and its receptor in bronchiolitis obliterans organizing
pneumonia (BOOP). Am J Respir Crit Care Med 1994;
R200: A20.
14. Cohen AJ, King TE, Downey GP. Rapidly progressive
bronchiolitis obliterans with organizing pneumonia.
Am J Respir Crit Care Med 1994; 149: 1670–1675.
15. Costabel U, Teschler H, Guzman J. Bronchiolitis
obliterans organizing pneumonia (BOOP): the cytolo-
gical and immunocytological profile of bronchoalveo-
lar lavage. Eur Respir J 1992; 5: 791–797.
16. Dina R, Sheppard MN. The histological diagnosis of
clinically documented cases of cryptogenic organizing
pneumonia: diagnostic features in transbronchial biop-
sies. Histopathology 1993; 23: 541–545.
17. Poletti V, Cazzato S, Minicuci N, et al. The diagnostic
value of bronchoalveolar lavage and transbronchial
lung biopsy in cryptogenic organizing pneumonia. Eur
Respir J 1996; 9: 2513–2516.
18. Zompatori M, Poletti V. Imaging of small airways
diseases, with emphasis on HRCT.Monaldi Arch Chest
Dis 1997; 52: 242–248.
19. Yousem SA, Lohr RH, Colby TV. Idiopathic
bronchiolitis obliterans organizing pneumonia/
cryptogenic organizing pneumonia with unfavorable
outcome: pathologic predictors. Mod Pathol 1997; 10:
864–871.
20. Usui Y, Kimula Y, Miura H, et al. A case of
bronchiolitis obliterans organizing pneumonia asso-
ciated with primary Sjogren’s syndrome who died of
superimposed diuse alveolar damage. Respiration
1992; 59: 122–124.
21. Cordier JF, Loire R, Brune J. Idiopathic bronchiolitis
obliterans organizing pneumonia:definition of charac-
teristics clinical profiles in a series of 16 patients. Chest
1989; 96: 999–1004.
708 S. CAZZATO ET AL.22. Poletti V, Vinelli M, Giovannitti A, et al. Bronchoal-
veolar lavage (BAL): its role in the diagnosis of ARDS/
diuse alveolar damage. In: Gullo A, ed. Anaesthesia
Pain Intensive Care and Emergency Medicine. Selected
Papers. Trieste: Trieste Club APICE, 1995; 20–23.
23. Lohr RH, Boland BJ, Doughlas WW, et al. Organizing
pneumonia: features and prognosis of cryptogenic,secondary, and localized variant. Arch Intern Med
1997; 157: 1323–1329.
24. Costabel U, Guzman J, Teschler H. Bronchiolitis
obliterans with organizing pneumonia: outcome. Thor-
ax 1995; 50: S59–S64.
